Ovarian pain
This indicates glucosamine sulfate may be able to slow the natural progression of osteoarthritis of the knee. ovarian pain Driving with back pain. Of note, there were no differences in safety or early withdrawal between the placebo and treatment groups. All of the published reports on clinical trials of glucosamine in OA have resulted in favorable outcomes. Unfortunately, many of these studies have significant flaws in experimental design. ovarian pain Arthritis water slippers. Nevertheless, the data from a few quality studies discussed above are suggestive that glucosamine is effective in the control of pain symptoms and is potentially a disease-modifying agent in the treatment of knee OA. When taken orally, it is safe but there are few long-term data. Glucosamine may thus be effective in decreasing the symptoms of OA; however it should be recommended to patients with the attitude that additional long-term efficacy studies need to be performed. ovarian pain Natural pain relief. (top of section)(top of page) Chondroitin SulfateFrequently sold in combination with glucosamine, chondroitin sulfate is a proteoglycan and a major component of articular cartilage. It is hypothesized to work by increasing levels of chondroitin sulfate in the blood and subsequent incorporation into the cartilage. Additionally, in vitro studies have demonstrated that chondroitin sulfate can stimulate production of other important cartilage proteoglycans. ref 4 & 7 A number of clinical studies have now demonstrated that chondroitin sulfate therapy does indeed produce clinical benefits. Bourgeois et alref 8 conducted a multicenter, randomized, double-blind, controlled study which compared 1200 mg/day chondroitin sulfate to placebo. One hundred twenty-seven patients were randomized to receive either placebo, chondroitin sulfate 1200 mg/day, or chondroitin sulfate 3x400 mg/day. In the chondroitin sulfate groups, the Lequesne's Index, and the patient and physician overall assessments were significantly improved compared to baseline (P<0. 01 for both assessments). In contrast, there was only a slight improvement observed in the placebo group. Both the physician's and patient's overall efficacy assessments were significantly better in the chondroitin sulfate group than in the placebo group (P<0. 01). Of note, there was no difference in efficacy between the single dose of 1200mg chondroitin sulfate and the 3x400mg daily doses of chondroitin sulfate for any of the clinical parameters studied. Morreale, et alref 9 conducted a randomized, multicenter, double blind, double dummy study comparing the efficacy of chondroitin sulfate with diclofenac sodium, a commonly used anti-inflammatory drug. One hundred forty-six patients with OA of the knee were randomized to receive either chondroitin sulfate or diclofenac sodium for six months. Patients who had received diclofenac sodium had a quick decrease in pain symptoms which, however, reappeared after the end of treatment. A clinical reduction in symptoms was observed later in time in patients who had received chondroitin sulfate, but the symptoms did not reappear for up to 3 months after the end of treatment. A recent metaanalysisref 10 of seven studies including the two discussed above concluded that chondroitin sulfate may be useful in decreasing pain and improving function in osteoarthritis. Pooled data showed at least a 50% improvement in VAS pain scores and the Lequesne functional index.
Ovarian pain
Wrist || Right-abdominal-pain || Arthritis-dogs || Information-on-rhematoid-arthritis